CereVasc
Tracked across 1 events · 6 articles · First seen Jun 04, 2026 · Last active Jun 04, 2026
Live sentiment trends, attention charts, and prominence tracking available on the
NewsDesk Dashboard
Business
CereVasc, a clinical-stage medical device company, has successfully completed an initial closing of an $85 million Series C financing. The financing was led by Piper Sandler Companies Merchant Banking, with significant participation from new investors…
Impact: CereVasc successfully completed an $85 million Series C financing, which will fund the continued clinical and regulatory development of its eShunt System, including the STRIDE pivotal trial, and preparations for US commercialization. This financing significantly advances the company's growth and product development.
Jun 04, 2026 · 6 articles
100
CereVasc completed Series C financingCereVasc secures $85M Series C
90
Piper Sandler Companies led financing round CereVascCereVasc secures $85M Series C
70
Johnson & Johnson participated in financing CereVascCereVasc secures $85M Series C
70
Medtronic participated in financing CereVascCereVasc secures $85M Series C
60
CereVasc strengthened Board of DirectorsCereVasc secures $85M Series C
50
Bain Capital participated in financing CereVascCereVasc secures $85M Series C
50
Perceptive Advisors participated in financing CereVascCereVasc secures $85M Series C
NEWSDESK
Track CereVasc live
Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.
Open Dashboard